glp-1 long-term side effects cancer Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND) Glucagon-like peptide 1 receptor agonists

Specifically, future work should prioritize conducting specific animal studies to validate the hypothesized anti-fibrotic and anti-cancer effects of GLP-1 RAs in ALD and MetALD models

Increases energy expenditure

Isolated GH axis intervention without attention to these interacting systems may produce suboptimal outcomes

Anyone with cancer history should consult their oncologist before considering Tesamorelin

"L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial." J Clin Oncol 30(31): 3864-3869

L-Carnitine is a naturally occurring compound derived from the amino acids lysine and methionine